Trial intelligence / Profile preview

Aprepitant plus Ondansetron for PONV in Ambulatory Plastic Surgery

NCT00659945Phase 4Completed

Sponsor
University of Pittsburgh
Start
Jun 2008
Primary completion
Nov 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aprepitant in postoperative nausea and vomiting (PONV), sponsored by University of Pittsburgh. Started Jun 2008; status: completed.

02

Drugs

aprepitant
03

Conditions

postoperative nausea and vomiting (PONV)

Beyond the preview

Go deeper on NCT00659945.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00659945.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call